Zoetis Polska Sp. z o.o.
+ business areaBioPharma R&D+Services
+ annual revenue
2020 - 219,300,000 PLN
2021 - 229,700,000 PLN
2022 - 280,100,000 PLN
2023 - 363,900,000 PLN
2024 - 427,700,000 PLN
+ workforce (estimated if not reported)
2024 - 241
+ depreciation & amortization
2020 - 1,500,000 PLN
2021 - 1,700,000 PLN
2022 - 2,300,000 PLN
2023 - 4,100,000 PLN
2024 - 4,800,000 PLN
Zoetis is a global animal health company focused on developing and supplying veterinary medicines, vaccines, diagnostics, and technical services. It operates in Poland as Zoetis Polska Sp. z o.o., supporting the veterinary sector.